Eck Stephen L. 4
4 · MACROGENICS INC · Filed Feb 12, 2024
Insider Transaction Report
Form 4
MACROGENICS INCMGNX
Eck Stephen L.
Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2024-02-08+90,000→ 90,000 totalExercise: $18.30Exp: 2034-02-08→ Common Stock (90,000 underlying) - Award
Restricted Stock Unit
2024-02-08+33,500→ 33,500 totalExercise: $0.00→ Common Stock (33,500 underlying)
Footnotes (3)
- [F1]12.5% of the shares underlying the grant became exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter.
- [F2]Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock.
- [F3]The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.